Search details
1.
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort.
Rheumatology (Oxford)
; 63(2): 472-481, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-37228011
2.
Is HLA type a possible cancer risk modifier in Lynch syndrome?
Int J Cancer
; 152(10): 2024-2031, 2023 05 15.
Article
in English
| MEDLINE | ID: mdl-36214792
3.
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination.
Br J Cancer
; 128(9): 1777-1787, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36823366
4.
Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.
Ann Rheum Dis
; 82(3): 357-364, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36241361
5.
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.
Ann Rheum Dis
; 82(5): 670-680, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36653124
6.
Improved outcomes in rheumatoid arthritis with obesity after a weight loss intervention: randomized trial.
Rheumatology (Oxford)
; 62(2): 565-574, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-35640116
7.
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.
Rheumatology (Oxford)
; 62(12): 3785-3800, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37335850
8.
Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy prediction.
Clin Exp Rheumatol
; 41(2): 330-339, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36861746
9.
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
Am J Respir Crit Care Med
; 205(6): 674-684, 2022 03 15.
Article
in English
| MEDLINE | ID: mdl-34851799
10.
Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
Ann Rheum Dis
; 81(3): 379-385, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34462261
11.
Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis.
Rheumatology (Oxford)
; 62(1): 234-242, 2022 12 23.
Article
in English
| MEDLINE | ID: mdl-35583273
12.
Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis.
Rheumatology (Oxford)
; 61(4): 1385-1395, 2022 04 11.
Article
in English
| MEDLINE | ID: mdl-34142111
13.
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.
Rheumatology (Oxford)
; 61(10): 4155-4162, 2022 10 06.
Article
in English
| MEDLINE | ID: mdl-35108379
14.
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails.
Blood
; 135(16): 1386-1395, 2020 04 16.
Article
in English
| MEDLINE | ID: mdl-31932846
15.
Predictive model of risk and severity of enteritis in systemic lupus erythematosus.
Lupus
; 31(10): 1226-1236, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35750508
16.
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
N Engl J Med
; 378(1): 35-47, 2018 01 04.
Article
in English
| MEDLINE | ID: mdl-29298160
17.
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group.
Ann Rheum Dis
; 80(2): 242-249, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33055082
18.
Trend in women representation among authors of high rank rheumatology journals articles, 2002-2019.
Rheumatology (Oxford)
; 60(11): 5127-5133, 2021 11 03.
Article
in English
| MEDLINE | ID: mdl-33560297
19.
Performance of 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in a paediatric population-a multicentre study.
Rheumatology (Oxford)
; 60(11): 5142-5148, 2021 11 03.
Article
in English
| MEDLINE | ID: mdl-33560345
20.
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects.
Br J Clin Pharmacol
; 87(11): 4323-4333, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33822406